Illumina (ILMN) Optics for Genomics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Illumina (ILMN) Optics for Genomics

ILMN 122.42

+4.7%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Elmer who started this subject	6/12/2003 8:00:11 PM
From: mopgcw	Read Replies (1) of 276

Illumina Announces Sentrix BeadChip Platform Thursday June 12, 8:05 am ET New Microarray Substrate Complements Sentrix Fiber-Based Array Matrix Photo Editors/Business Editors/Health/Medical Writers BIOWIRE2K NOTE TO MEDIA: Multimedia assets available A photo is available at URL: businesswire.com SAN DIEGO--(BUSINESS WIRE)--June 12, 2003--Illumina, Inc. (Nasdaq: ILMN - News) announced today that it has developed and is manufacturing a novel microarray substrate that will significantly expand market opportunities for its BeadArray(TM) technology and provide increased experimental flexibility for life science researchers. Source: Illumina, Inc. · Learn more about this product · Learn more about company · View multimedia news release Sentrix(TM) BeadChips are manufactured using highly flexible MEMS (microelectronic mechanical systems) technology, allowing creation of any number of microfabricated wells clustered into discrete regions on a substrate. These regions are populated with beads, and the resulting BeadChip is processed using the same methods perfected for the fiber-based Sentrix Array Matrix. Each region can interrogate a separate sample and can be configured in different sizes and densities -- standard and custom -- depending on researcher requirements. Initial BeadChip formats will be sized like standard slide arrays. Additional sizes can be added to the line to accommodate custom configurations. The BeadChip format will supplement the Sentrix fiber-based array matrices now being used by Illumina's production genotyping services operation and by the Company's BeadLab customers. Collectively, the expanded line of Sentrix arrays delivers even greater power to the multi-sample Array of Arrays® approach that Illumina invented and introduced to the high-throughput genomics market. Sentrix BeadChips will support the same applications as the Company's fiber array matrices, including SNP genotyping and RNA profiling. Sets of beads with immobilized probe sequences can be deployed interchangeably on both substrates. Jay Flatley, Illumina President and CEO, stated "We have invested heavily in the development of this complementary new platform and we're excited to bring the expanded technology into the marketplace. The Sentrix platform addition will give researchers the flexibility to use our technology over a wider range of samples and probes, and enable individual projects to be conducted on a smaller scale than that required in production-scale facilities now using the Array Matrix. We expect our first BeadChip-based products to be launched over the next few quarters." Illumina (www.illumina.com) is developing next-generation tools that permit large-scale analysis of genetic variation and function. The Company's proprietary BeadArray(TM) technology provides the throughput, cost effectiveness and flexibility to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics. This information will help pave the way to personalized medicine.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next